These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25623121)

  • 1. Obesity. A new paradigm for treating obesity and diabetes mellitus.
    Scheen AJ; Paquot N
    Nat Rev Endocrinol; 2015 Apr; 11(4):196-8. PubMed ID: 25623121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vitamin D, obesity, and diabetes:new technology toward drug development against metabolic diseases].
    Miyata Y; Shimomura I
    Clin Calcium; 2016 Mar; 26(3):385-91. PubMed ID: 26923975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes in Zucker diabetic fatty rat.
    Shiota M; Printz RL
    Methods Mol Biol; 2012; 933():103-23. PubMed ID: 22893404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Apelin Peptides on Diabetic Complications.
    Chen H; Liu C; Cheng C; Zheng L; Huang K
    Curr Protein Pept Sci; 2018; 19(2):179-189. PubMed ID: 28925900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction.
    Wong CC; Yu J
    Adv Exp Med Biol; 2018; 1061():1-2. PubMed ID: 29956202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a causal role of oxidative stress in the myocardial complications of insulin resistance.
    Ritchie RH
    Heart Lung Circ; 2009 Feb; 18(1):11-8. PubMed ID: 19119069
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms].
    Zhang Q; Li Y; Chen L
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(9):1660-5. PubMed ID: 26323125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic memory: implications for diabetic vascular complications.
    Cooper ME
    Pediatr Diabetes; 2009 Aug; 10(5):343-6. PubMed ID: 19490497
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatocellular Carcinoma in Obesity: Finding a Needle in the Haystack?
    Baffy G
    Adv Exp Med Biol; 2018; 1061():63-77. PubMed ID: 29956207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes-accelerated atherosclerosis and inflammation.
    Kanter JE; Averill MM; Leboeuf RC; Bornfeldt KE
    Circ Res; 2008 Oct; 103(8):e116-7. PubMed ID: 18845812
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.
    Fokkens BT; Smit AJ
    Glycoconj J; 2016 Aug; 33(4):527-35. PubMed ID: 27287226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A role of alimentary factor in insulin resistance at type 2 diabetes].
    Zykina VV; Sharafetdinov KhKh; Plotnikova OA
    Vopr Pitan; 2007; 76(5):28-34. PubMed ID: 18030810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The metabolic syndrome--clinical significance in 2011. Position statement of the Hungarian Diabetes Society, Metabolism Work Group].
    Barkai L; Halmos T; Hidvégi T; Jermendy G; Korányi L; Madácsy L; Pados G; Winkler G;
    Orv Hetil; 2011 Sep; 152(36):1450-8. PubMed ID: 21865147
    [No Abstract]   [Full Text] [Related]  

  • 14. A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus.
    Thondam SK; Cuthbertson DJ; Aditya BS; Macfarlane IA; Wilding JP; Daousi C
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):635-7. PubMed ID: 22356092
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
    Owecki M; Sowiński J
    Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating type 2 diabetes mellitus with sleeve gastrectomy in obese patients.
    Gill RS; Karmali S; Sharma AM
    Obesity (Silver Spring); 2011 Apr; 19(4):701-2. PubMed ID: 20966914
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of vitamin D deficiency on diabetes and cardiovascular risk.
    Baz-Hecht M; Goldfine AB
    Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):113-9. PubMed ID: 20150805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of obesity and leptin with insulin resistance in type 2 diabetes mellitus in Indian population.
    Das P; Bhattacharjee D; Bandyopadhyay SK; Bhattacharya G; Singh R
    Indian J Physiol Pharmacol; 2013; 57(1):45-50. PubMed ID: 24020098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of peptide-based polyagonists for treatment of diabetes and obesity.
    Knerr PJ; Finan B; Gelfanov V; Perez-Tilve D; Tschöp MH; DiMarchi RD
    Bioorg Med Chem; 2018 Jun; 26(10):2873-2881. PubMed ID: 29153547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.